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Abstract
HIV-1 replication and viral pathogenesis are dependent on numerous host factors. A series of recent
papers apply genome-wide and large-scale approaches to map host-virus interactions and to identify
host proteins capable of restricting (that is, controlling) the virus. Strategies include genome-wide
association studies, small interfering RNA screens, genome-wide transcriptome profiling, proteome
studies, and the assessment of the role of host-encoded microRNAs in infection. The various layers
of large-scale data are brought together through meta-analytical procedures.
Introduction and context
HIV-1 research has traditionally led to or rapidly adopted
new approaches, tools, and concepts from the life
sciences. It is thus no surprise to witness the pace of
implementation of large-scale genome approaches in the
understanding of HIV-1 biology and pathogenesis. Recent
years have seen the publication of genome-wide associa-
tion studies, small interfering RNA (siRNA) screens, and
transcriptome and proteome analyses. These approaches
have a number of distinctive features: they focus more on
the host than on the virus, they are large-scale and are
inspired by the hope of discovery that is not ap r i o r i ,a n d
they bring into the field new researchers from different
and more quantitative fields. Moreover, the appetite for
novelty means that a number of increasingly available
tools and techniques – such as new sequencing equip-
ment – will rapidly contribute new layers of data.
I have purposefully used the expression ‘new layers of
data’ rather than ‘knowledge’ to emphasize the parallel
development of tools to visualize and integrate data and,
hopefully, create a more complete view of the makings of
HIV-1. Some experts have identified needs in the field
and are orchestrating the joint research efforts that
should bring about solutions to the enormous puzzle of
host-virus interactions. The present report builds on the
recent publication by Bushman and colleagues [1],
evaluated in Faculty of 1000 Medicine [2].
Major recent advances
The last two and a half years have seen a large number of
studies that use technical platforms to genotype the host
genome at high density; now between 500,000 and 1
million single-nucleotide polymorphisms are analyzed
per individual. Three publications have applied this
technology to the field of HIV-1. Fellay and colleagues
[3] investigated the genetic associations with the level of
viral load and with rates of disease progression. They
identified the major histocompatibility complex (MHC)
region in chromosome 6 as the main contributor to HIV-
1 control. Two later studies confirmed these findings
[4,5]. Currently, the field faces two challenges: (a) how to
identify the exact contributors to viral control within the
MHC, a region that contains the classical HLA genes as
well as other genes involved in inflammation and
immunity, and (b) how to bring the published and
additional follow-up studies into a joint study to
complete the assessment of the role of common
human variation in HIV-1 disease.
Four siRNA screens have been reported in the last year
and a half [6-9]. These studies used transfected libraries
of siRNA, or stably transduced short hairpin RNAs
(shRNAs), to knock down expression of more than
20,000 genes, followed by infection/transduction of the
cells by HIV. Combined, the three siRNA studies
identified more than 800 genes as being possibly
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by two or more screens. The more recent study using
shRNAs to stably silence Jurkat T cells had only six genes
shared with the other studies [9]. In addition, the study
design favored the identification of genes that supported
HIV replication; there are no data on genes that, when
knocked down, lead to increased viral replication (that
is, restriction factors).
There have been a number of transcriptome studies in
HIV-1 target cells (CD4
+ T cells, monocytes/macro-
phages), in non-targets such as natural killer cells and
B cells, and in dendritic cells and total peripheral blood
mononuclear cells (reviewed in [10]) [11-13]. Transcrip-
tome analyses of cell lines transfected with individual
viral proteins or mutant viruses have also been reported.
These studies provide insight into gene expression
changes associated with virus replication and persistence.
Studies are limited by the number of genes interrogated
or by the number of individuals investigated. However,
more recent work is bringing to the in vivo setting a more
dynamic measure of the transcriptome response to
infection in models of pathogenic and non-pathogenic
primate infection [14,15] as well as in human infection
[16].
RNA interference (RNAi) represents a vital component of
the innate anti-viral immune response in plants and
invertebrate animals. It also serves as a gene regulation
mechanism that is triggered by the expression of
microRNA (miRNA) molecules. Understanding the role
of cellular miRNAs in the defense against viral infection
in mammalian organisms and the influence of viral
replication on the abundance and distribution of
miRNAs within the host cell is a highly relevant research
question. Recent work highlights the role of miRNAs in
restriction of HIV-1 infection [17-19]. Triboulet and
colleagues [17] reported a role of Drosha and Dicer in
human cell defense against HIV-1. miRNAs act both
through direct targeting of the 3
0 untranslated region of
HIV-1 [18,19] and indirectly through modulation of the
cellular environment [17]. Huang and colleagues [18]
identified miR-28, miR-125b, miR-150, miR-223, and
miR-382 as contributing to HIV-1 latency in quiescent
CD4 T cells. Wang and colleagues [19] identified miR-28,
miR-150, miR-223, and miR-382 as possibly protecting
monocytes/macrophages from HIV-1 infection. Three
recent papers assessed the involvement of miRNA in
controlling HIV-1 replication: Chable-Bessia et al. [20]
showed that RNAi effectors repress HIV-1 replication
through HIV-1 mRNA targeting to processing bodies and
translational inhibition, and Ahluwalia et al. [21] and
Nathans et al. [22] evaluated the direct targeting of HIV-1
mRNA by cellular miR-29a. A recent report presented the
miRNA profile in peripheral mononuclear cells from 36
HIV-1-seropositive individuals and compared the profile
with that of 12 seronegative subjects [23].
Proteome studies have also been reported in recent times
in the field of HIV-1. Analysis of infected T cells by two-
dimensional in-gel electrophoresis detected 15% of
2,000 protein spots as differentially expressed at peak
infection [24]. Analysis of 3,200 proteins using liquid
chromatography-mass spectrometry coupled with stable
isotope labeling identified 21% of proteins as differen-
tially expressed upon infection [25]. Biological pathways
included ubiquitination, nucleocytoplasmic transport,
cell cycle progression, and the citrate cycle. The latter
study also identified changes in the abundance of
proteins with known interactions with HIV-1 viral
proteins [25]. The incorporation of host proteins to
viral particles has been investigated in the past [26]. The
National Center for Biotechnology Information main-
tains a HIV-host protein interaction database [27,28].
The National Institutes of Health has also committed to
a large effort on HIV structural biology by the funding of
three centers that are establishing a comprehensive
structural picture of interactions between HIV viral
proteins and intracellular host molecules and applying
new computational and functional methods for analyz-
ing virus/host complexes (the Center for the Structural
Figure 1. Genome-wide and large-scale cellular studies
published since 2007 in the field of HIV
The number of studies is in parenthesis. Diverse sets of results and data are
compiled in an encyclopedia of overlaps between studies [32]. This
approach serves to identify networks used by HIV-1 to support its
replication. miRNA, microRNA; siRNA, short interfering RNA.
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and Assembly of HIV [29], the University of California
San Francisco and Berkeley HIV Accessory and Regula-
tory Complexes Center [30], and the Pittsburgh Center
for HIV Protein Interactions [31]).
Studies such as those discussed above lead naturally to
the possibility of cross-evaluation and validation
(Figure 1). This effort, spearheaded by Bushman and
colleagues [1], used meta-analytical procedures to assess
nine genome-wide studies. While pairwise comparisons
of the studies resulted in modest overlaps, data analyses
in the context of cellular networks and subsystems led
to the identification of at least 11 densely connected
clusters. These clusters, enriched for proteins identified in
multiple separate screens, specify cellular subsystems
associated with HIV replication: the proteasome, sub-
units of RNA polymerase II and associated factors, the
mediator complex, the Tat activation machinery, RNA-
binding and -splicing proteins, and the BiP/GRP78/
HSPA5 and CCT chaperones. The study went one
additional step to organize data in an ‘encyclopedia’ of
host factors assisting HIV replication [32]. The growing
need for analyzing layers of data in the genomic context
has also led to the development of ‘viewers’. These are
web-based tools designed for visualization of large-scale
genetic and genomic data, allowing the aggregation or
intersection of diverse data tracks [33,34].
Future directions
Novel technology and the accumulation of genome data
across species will contribute additional layers to the
analyses. Examining intra- and inter-species genome data
under the principles of comparative and evolutionary
genomics gives investigators the potential to map genes
under positive selective pressure due to pathogens.
Chromatin immunoprecipitation combined with deep
sequencing or with microarrays will provide more
quantitative data of mRNA expression, on small non-
coding RNAs, and from experiments on epigenetic
reprogramming due to infection [35]. Particularly
attractive techniques are those using ribosome profiling
to generate precise quantitative data on the precise
mRNA that is being translated – a closer surrogate of
protein expression than that afforded by conventional
transcriptome profiles [36]. Eventually, integration of
data will complement or guide experiments designed to
capture large-scale data in cycles of experimental
perturbation – the core definition of systems biology.
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